Article Text

other Versions

Download PDFPDF
PGAM5: a new player in immune-mediated liver injury
  1. Anup Ramachandran,
  2. Hartmut Jaeschke
  1. Department of Pharmacology, Toxicology & Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA
  1. Correspondence to Dr Hartmut Jaeschke, Department of Pharmacology, Toxicology & Therapeutics, University of Kansas Medical Center, 3901 Rainbow Blvd, MS 1018, Kansas City, KS 66169, USA; hjaeschke{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Mechanisms of cell death are critical in any pathophysiology and hence have been extensively investigated in a number of different organ systems. Initially, the term ‘programmed cell death’ was exclusively applied to apoptosis, where molecular mediators and signalling pathways involved in the process were relatively well characterised. The other form of cell death, namely necrosis, was considered to be an uncontrolled process, where catastrophic events within the cell resulted in a rupture of the plasma membrane with release of cell contents. However, this paradigm has been rapidly evolving as new pathways and mediators, which control necrotic cell death, are discovered. It is now clear that whenever cells die by necrosis, they do so in an ordered systematic manner, which, not surprisingly, shares some components with the apoptotic pathway. This is especially relevant in the liver, where apoptosis was considered to be the main form of cell death in a large number of contexts. These concepts are now changing based on the identification of specific mediators involved in programmed necrosis in response to a number of insults in the liver. The new study from He et al1 in this issue now identifies mitochondrial phosphoglycerate mutase/protein phosphatase 5 (PGAM5) as another key mediator in physiologically relevant cell death in the liver, …

View Full Text


  • Contributors Both authors contributed equally to conception and writing of this editorial.

  • Funding Work in this laboratory was supported in part by the National Institutes of Health grants R01 DK102142 and R01 AA12916, and by grants from the National Institute of General Medical Sciences (8 P20 GM103549-09 and 1P30 GM118247-01) from the National Institutes of Health.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles